Induction and dosing

Description: 
Journal abstract that examines whether there's an association of ethnicity and race with treatment response to buprenorphine.
Source: 
Brown, et al., Department of Psychiatry, The University of Texas Southwestern Medical Center
0
Your rating: None
Description: 
This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
Source: 
Physician Clinical Support System (PCSS)
0
Your rating: None
Description: 
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides this website so that physicians can improve the deliver and financing of prevention, treatment and recovery support services to patients.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
0
Your rating: None
Description: 
Buprenorphine tablets are approved for the treatment of opiate dependence. Buprenorphine treats opiate addiction by preventing symptoms of withdrawal from heroin and other opiates.
Source: 
Food and Drug Administration (FDA)
0
Your rating: None
Description: 
This 2009 article discusses a study of home induction for buprenorphine treatment; the results supported the hypothesis that home induction is a feasible and safe option.
Source: 
J Gen Intern Med.
0
Your rating: None
Description: 
This document discusses the logistics of successful buprenorphine induction, offering insight into clinical questions that should be addressed, the goal of induction, general principles, and recommendations based on low and high levels of evidence. Recommendations are included for both in-office and at-home inductions.
Source: 
Physician Clinical Support System (PCSS)
4
Your rating: None Average: 4 (2 votes)
Description: 
This abstract discusses a study done on the feasibility of an unobserved buprenorphine induction protocol. The study involved 103 patients who were heroin users and prescription opioid misusers, and discusses safety and rates of complications from induction through follow-up.
Source: 
Journal of General Internal Medicine
4
Your rating: None Average: 4 (2 votes)
Description: 
This is a basic form that helps physicians keep track of when and what quantity of buprenorphine they dispense.
Source: 
American Academy of Addiction Psychiatry (AAAP)
4.666665
Your rating: None Average: 4.7 (3 votes)
Syndicate content